Supplemental material
OncoImmunology
Volume 7, 2018 - Issue 7
Original Research
Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma
Xinqi WuDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
http://orcid.org/0000-0003-4979-4596 http://orcid.org/0000-0003-4979-4596 http://orcid.org/0000-0003-4979-4596View further author information
http://orcid.org/0000-0003-4979-4596 http://orcid.org/0000-0003-4979-4596 http://orcid.org/0000-0003-4979-4596View further author information , , , , , Mariano SevergniniDepartment of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA;Center for Immuno-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MAhttp://orcid.org/0000-0001-6783-8500View further author information
http://orcid.org/0000-0001-6783-8500View further author information, , & show allRelated Research Data
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Source:
Frontiers Media SA
Linking provided by
